Evidence map›Paper›PMID 33175366›Full record

ArticlePharmacological reports : PR2021

Involvement of the ventral, but not dorsal, hippocampus in anxiety-like behaviors in mice exposed to the elevated plus maze: participation of CRF1 receptor and PKA pathway.

Natalia Bonetti Bertagna, Paulla Giovanna Cabral Dos Santos, Rafaella Misael Queiroz, Gustavo Juliate Damaceno Fernandes, Fabio Cardoso Cruz, Tarciso Tadeu Miguel

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmacological reports : PR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Sex-Dependent Modulation of AMPA and GABACurrent neuropharmacology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Natalia Bonetti BertagnaPharmacology Laboratory, Pharmacology Department, Biomedical Sciences Institute, Federal University of Uberlândia (UFU), Av. Pará, 1720, Bloco 2A, Uberlândia, MG, 38405-320, Brazil.
Paulla Giovanna Cabral Dos SantosPharmacology Laboratory, Pharmacology Department, Biomedical Sciences Institute, Federal University of Uberlândia (UFU), Av. Pará, 1720, Bloco 2A, Uberlândia, MG, 38405-320, Brazil.
Rafaella Misael QueirozPharmacology Laboratory, Pharmacology Department, Biomedical Sciences Institute, Federal University of Uberlândia (UFU), Av. Pará, 1720, Bloco 2A, Uberlândia, MG, 38405-320, Brazil.
Gustavo Juliate Damaceno FernandesPharmacology Laboratory, Pharmacology Department, Biomedical Sciences Institute, Federal University of Uberlândia (UFU), Av. Pará, 1720, Bloco 2A, Uberlândia, MG, 38405-320, Brazil.
Fabio Cardoso CruzPsychopharmacology Laboratory, Pharmacology Department, Federal University of São Paulo, São Paulo, Brazil.
Tarciso Tadeu MiguelPharmacology Laboratory, Pharmacology Department, Biomedical Sciences Institute, Federal University of Uberlândia (UFU), Av. Pará, 1720, Bloco 2A, Uberlândia, MG, 38405-320, Brazil. tarciso.miguel@ufu.br.
Universidade Federal de Uberlândia · BRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe hippocampus is a limbic structure involved in anxiety-like behaviors. We aimed to evaluate the role of the dorsal (DH) and ventral (VH) hippocampus in anxiety-like behaviors in the elevated plus maze (EPM).

methodsWe inhibited these brain regions using cobalt chloride (CoCl

resultsThe results indicated that intra-VH CoCl

conclusionsThis study demonstrated that VH modulates anxiety-like behaviors in EPM. Moreover, CRF and the cAMP/PKA pathway seem to modulate these effects.

Indexed as

AminopyridinesAnimalsAnxietyBehavior, AnimalCobaltCRF Receptor, Type 1Cyclic AMP-Dependent Protein KinasesHippocampusIsoquinolinesMaleMaze LearningMiceMicroinjectionsMotor ActivityProtein Kinase InhibitorsReceptors, Corticotropin-Releasing Hormone(3,6-dimethyl-2-(2,4,6-trimethylphenoxy)pyridin-4-yl)(1-ethylpropyl)amineAminopyridinesCobaltcobaltous chlorideCRF Receptor, Type 1Cyclic AMP-Dependent Protein KinasesIsoquinolinesN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamideProtein Kinase InhibitorsReceptors, Corticotropin-Releasing HormoneSulfonamidesAnxietyCorticotropin-releasing factorCRF1 receptorElevated plus mazeHippocampusProtein kinase A

Identifiers

PMID33175366
OpenAlexW3098670954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.